Health
Genome editing to treat human retinal degeneration – EurekAlert
Gene editing therapies, including CRISPR-Cas systems, offer the potential to correct mutations causing inherited retinal degenerations, a leading cause of blindness….
IMAGE: Provides all-inclusive access to the critical pillars of human gene therapy: research, methods, and clinical applications.
view more
Credit: Mary Ann Liebert, Inc., publishers
New Rochelle, NY, January 19, 2021–Gene editing therapies, including CRISPR-Cas systems, offer the potential to correct mutations causing inherited retinal degenerations, a leading cause of blindness. Technological advances in gene editing, continuing safety concerns, and strategies to overcome these challenges are…
-
Business21 hours agoThe pros and cons of buying CBA shares in September
-
Noosa News21 hours agoRent changes on way for hundreds of social housing recipients following government review
-
Business17 hours agoWhere will Berkshire Hathaway be in 1 year?
-
Noosa News19 hours agoPolice reject claims about detained protester; SEQ train lines to be disrupted; BlueCare to cut enrolled nurses